Mirova’s Johnson & Johnson JNJ Stock Holding History

Mirova’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,159	Closed	-$302K	–	131
2019 Q1	$302K	Buy	2,159 +643	+42%	+$86.1K	0.16%	23
2018 Q4	$196K	Buy	+1,516	New	+$211K	0.09%	36

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Mirova's JNJ Position: Q2 2019 in Review

Mirova sold out of Johnson & Johnson (JNJ) in Q2 2019, closing a stake of 2,159 shares — an estimated $302K sold.

Mirova first reported a position in JNJ in Q4 2018 and held it in 2 quarters. The position peaked at $302K in Q1 2019. 2,756 funds tracked by Wall St. Rank hold JNJ as of Q2 2019.

Mirova reported no remaining Johnson & Johnson position as of Q2 2019 after selling out during the quarter.
Mirova sold 2,159 Johnson & Johnson shares in Q2 2019, an estimated $302K.
Mirova first reported a position in Johnson & Johnson in Q4 2018 and held it in 2 quarters.
Mirova's Johnson & Johnson position peaked at $302K in Q1 2019.
2,756 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2019.

Based on Mirova's 13F filing for Q2 2019, filed 13 Aug 2019.